Although recent studies suggest that PMN-MDSCs have a higher expression of lipid transport proteins such as CD36 [12, 13], little is known regarding the expression of these and other neutrophil markers at different anatomical sites relevant to cancer (e.g., tumor, TDLN, etc.), as well as their association with metastasis. This evidence concerns the gene CD36 and cancer.